Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1897 1
1968 1
1970 2
1971 4
1977 1
1980 1
1982 6
1983 2
1987 2
1989 2
1993 1
1994 4
1995 5
1998 1
1999 1
2001 6
2002 2
2003 3
2004 6
2005 3
2006 3
2007 5
2008 6
2009 4
2010 4
2011 3
2012 3
2013 2
2014 5
2015 3
2016 1
2017 7
2018 5
2019 2
2020 4
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Results by year
Filters applied: . Clear all
Page 1
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.
Kochenderfer JN, Wilson WH, Janik JE, Dudley ME, Stetler-Stevenson M, Feldman SA, Maric I, Raffeld M, Nathan DA, Lanier BJ, Morgan RA, Rosenberg SA. Kochenderfer JN, et al. Among authors: lanier bj. Blood. 2010 Nov 18;116(20):4099-102. doi: 10.1182/blood-2010-04-281931. Epub 2010 Jul 28. Blood. 2010. PMID: 20668228 Free PMC article. Clinical Trial.
Considerations in difficult-to-control asthma.
Lanier BQ, Tierce M 4th. Lanier BQ, et al. Int Forum Allergy Rhinol. 2015 Sep;5 Suppl 1:S57-60. doi: 10.1002/alr.21593. Int Forum Allergy Rhinol. 2015. PMID: 26335837 Review.
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.
Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC. Johansson SG, et al. Among authors: lanier bq. J Allergy Clin Immunol. 2004 May;113(5):832-6. doi: 10.1016/j.jaci.2003.12.591. J Allergy Clin Immunol. 2004. PMID: 15131563
Safety and tolerability of omalizumab.
Corren J, Casale TB, Lanier B, Buhl R, Holgate S, Jimenez P. Corren J, et al. Among authors: lanier b. Clin Exp Allergy. 2009 Jun;39(6):788-97. doi: 10.1111/j.1365-2222.2009.03214.x. Epub 2009 Mar 17. Clin Exp Allergy. 2009. PMID: 19302249 Review.
Tissue loss with subcutaneous immunotherapy--Nicolau syndrome.
Tierce ML 4th, Schultz SM, Lanier BQ. Tierce ML 4th, et al. Among authors: lanier bq. J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):154-5. doi: 10.1016/j.jaip.2015.07.014. Epub 2015 Sep 8. J Allergy Clin Immunol Pract. 2016. PMID: 26362220 Review. No abstract available.
Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience.
Chipps BE, Lanier B, Milgrom H, Deschildre A, Hedlin G, Szefler SJ, Kattan M, Kianifard F, Ortiz B, Haselkorn T, Iqbal A, Rosén K, Trzaskoma B, Busse WW. Chipps BE, et al. Among authors: lanier b. J Allergy Clin Immunol. 2017 May;139(5):1431-1444. doi: 10.1016/j.jaci.2017.03.002. J Allergy Clin Immunol. 2017. PMID: 28477722 Free article. Review.
Pathophysiology and progression of nasal septal perforation.
Lanier B, Kai G, Marple B, Wall GM. Lanier B, et al. Ann Allergy Asthma Immunol. 2007 Dec;99(6):473-9; quiz 480-1, 521. doi: 10.1016/S1081-1206(10)60373-0. Ann Allergy Asthma Immunol. 2007. PMID: 18219827 Review.
106 results